Stephen Mayo, Director at Allogene Therapeutics, Inc. (ALLO), sold 10,000 shares at $4.29 ($43K) on 2023-08-07, disclosed to the SEC on 2023-08-09.
Open-market sale of $43k ALLO by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| SRPT | SELL | 2022-11-21 | $189K | — | Filing → |